drchrono Announces Partnership with HDP Health
drchrono Inc. announced that it has partnered with HDP Health to provide physicians and medical facilities with access to thousands of the latest clinical trials for their patients. HDP Health's software has locked in with drchrono's platform in order to identify and let patients know when they are eligible for a clinical trial or if a new one opens up. Physicians will also be informed if their patients are a fit for a particular trial.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
